| Source: |
| Type: |
| LIFR - Leukemia Inhibitory Factor Receptor Abbreviation: LIFR, CD118 Type: Cytokine receptor / gp130-family receptor Function: Cell-surface cytokine receptor that forms signaling complexes with gp130 (IL6ST) and responds to leukemia inhibitory factor (LIF) and related cytokines. LIFR signaling activates pathways including JAK/STAT3, MAPK/ERK, PI3K/AKT, and mTOR and regulates cell survival, differentiation, proliferation, stemness, inflammation, and tissue remodeling. Cancer: ↕ Context-dependent. Increased LIF/LIFR signaling is oncogenic in many solid tumors and can promote proliferation, survival, cancer stem-cell properties, invasion, metastasis, immune suppression, and resistance to therapy. However, LIFR can function as a metastasis suppressor in selected cancers, making its effect dependent on tumor type and signaling context. |
| 7445- | CYN, | Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis |
| - | vitro+vivo, | CRC, | RKO | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | DLD1 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1641 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid